{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:06:24Z","timestamp":1784552784394,"version":"3.55.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcoidosis is a heterogeneous disease with unknown mechanisms, nonspecific therapies, and multiple etiologies. The role of blood extracellular vesicles (EVs) in the diagnosis and pathogenesis of sarcoidosis remains obscure. AIMS. This study aims to test the hypothesis that the EV proteins in the blood can serve as phenotypic biomarkers of sarcoidosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We combined EV proteomics with machine learning algorithms to identify and prioritize biomarkers, enrich their functions, and cluster networks in case-control matched ACCESS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 278 plasma EV proteins were significantly upregulated or downregulated in 40 sarcoidosis patients compared with 40 matched healthy controls. We identified 97 proteins that could serve as biomarkers with an AUC &amp;gt; 0.75. Of these, the AUC was &amp;gt; 0.90 for 13 proteins. 62 differentially expressed EV proteins strongly correlated with 20 clinical variables of severity, chest X-ray findings, and\/or laboratory results. Functional annotation and network analysis suggest that these differentially expressed proteins regulate endocytosis, host responses to external stimuli, and transcription processes. Moreover, the top three ranked pathways were clathrin-mediated endocytosis, Hsp90 chaperone cycle, and spliceosome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates that plasma EV proteins can serve as biomarkers of various clinical phenotypes of the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1779835","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:08:27Z","timestamp":1776406107000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["New proteomic biomarkers identified in plasma extracellular vesicles in sarcoidosis: a case-control matched study"],"prefix":"10.3389","volume":"17","author":[{"given":"Runzhen","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Surgery, Stritch School of Medicine, Loyola University Chicago Health Sciences Division","place":["Maywood, IL, United States"]},{"name":"Burn and Shock Trauma Research Institute, Stritch School of Medicine, Loyola University Chicago Health Sciences Division","place":["Maywood, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan Miles","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Stritch School of Medicine, Loyola University Chicago Health Sciences Division","place":["Maywood, IL, United States"]},{"name":"Department of Mathematics and Statistics, Loyola University Chicago","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Lea","sequence":"additional","affiliation":[{"name":"Biomedical Engineering & Medicine, University of Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Department of Medicine, Loyola University Chicago","place":["Maywood, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Vanarsa","sequence":"additional","affiliation":[{"name":"Biomedical Engineering & Medicine, University of Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Surgery, Stritch School of Medicine, Loyola University Chicago Health Sciences Division","place":["Maywood, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dee","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Stritch School of Medicine, Loyola University Chicago Health Sciences Division","place":["Maywood, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Loyola University Chicago","place":["Maywood, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[{"name":"Biomedical Engineering & Medicine, University of Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Albany Einstein College of Medicine","place":["Albany, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Koth","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Long","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Surgery, Stritch School of Medicine, Loyola University Chicago Health Sciences Division","place":["Maywood, IL, United States"]},{"name":"Burn and Shock Trauma Research Institute, Stritch School of Medicine, Loyola University Chicago Health Sciences Division","place":["Maywood, IL, United States"]},{"name":"Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago Health Sciences Division","place":["Maywood, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/a-2768-2520","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/mcp.0b013e3283043de7","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1513\/annalsats.201303-069fr","article-title":"Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes","volume":"10","author":"Patterson","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2023.2183193","article-title":"An expert overview of pulmonary fibrosis in sarcoidosis","volume":"17","author":"Gupta","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.03.002","article-title":"Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum","volume":"101","author":"Bons","year":"2007","journal-title":"Respir Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13792","article-title":"Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement","volume":"44","author":"Thi Hong Nguyen","year":"2017","journal-title":"J Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/biom8030084","article-title":"YKL-40, soluble IL-2 receptor, angiotensin converting enzyme and C-reactive protein: Comparison of markers of sarcoidosis activity","volume":"8","author":"Uysal","year":"2018","journal-title":"Biomolecules"},{"key":"B10","first-page":"8","article-title":"Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis","volume":"37","author":"Miyata","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000725","article-title":"Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis","volume":"7","author":"Otto","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2020.1751614","article-title":"Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis","volume":"14","author":"Schimmelpennink","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxac009","article-title":"Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles","volume":"34","author":"Futami","year":"2022","journal-title":"Int Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.04.144","article-title":"Urinary 8-hydroxy-2\u2019-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis","volume":"190","author":"Kobayashi","year":"2015","journal-title":"Int J Cardiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.03.003","article-title":"An oxidative stress biomarker, urinary 8-hydroxy-2\u2019-deoxyguanosine, predicts cardiovascular-related death after steroid therapy for patients with active cardiac sarcoidosis","volume":"212","author":"Myoren","year":"2016","journal-title":"Int J Cardiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.117.006764","article-title":"Urinary 8-hydroxy-2\u2019-deoxyguanosine as a myocardial oxidative stress marker is associated with ventricular tachycardia in patients with active cardiac sarcoidosis","volume":"10","author":"Ishiguchi","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9754-4","article-title":"Human chitotriosidase: a sensitive biomarker of sarcoidosis","volume":"33","author":"Bargagli","year":"2013","journal-title":"J ClinImmunol"},{"key":"B18","article-title":"Bronchoalveolar lavage chitotriosidase activity as a biomarker of sarcoidosis","volume":"32","author":"Harlander","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1263-z","article-title":"Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis","volume":"21","author":"Bennett","year":"2020","journal-title":"Respir Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8565423","article-title":"Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6","volume":"2019","author":"Bergantini","year":"2019","journal-title":"Dis Markers"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-020-09158-0","article-title":"Utility of serological biomarker\u2019 panels for diagnostic accuracy of interstitial lung diseases","volume":"68","author":"Bergantini","year":"2020","journal-title":"Immunol Res"},{"key":"B22","first-page":"27","article-title":"Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis","volume":"27","author":"Handa","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A multiple biomarker approach in patients with cardiac sarcoidosis","volume":"59","author":"Kiko","year":"2018","journal-title":"Int Heart J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-020-01034-x","article-title":"Exosome detection via the ultrafast-isolation system: EXODUS","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Methods"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00044.2008","article-title":"Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs","volume":"295","author":"Gerszten","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00425-4","article-title":"A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19","volume":"3","author":"Lam","year":"2021","journal-title":"Nat Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2022.08.010","article-title":"Multi-omics analysis revealed the role of extracellular vesicles in hepatobiliary & pancreatic tumor","volume":"350","author":"Gongye","year":"2022","journal-title":"J Control Release"},{"key":"B28","doi-asserted-by":"publisher","first-page":"22191","DOI":"10.1038\/s41598-022-26473-8","article-title":"Coagulation potential and the integrated omics of extracellular vesicles from COVID-19 positive patient plasma","volume":"12","author":"Setua","year":"2022","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/proteomes10020012","article-title":"Multi-omics integrative approach of extracellular vesicles: A future challenging milestone","volume":"10","author":"Shaba","year":"2022","journal-title":"Proteomes"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151339","article-title":"Enabling metabolomics based biomarker discovery studies using molecular phenotyping of exosome-like vesicles","volume":"11","author":"Altadill","year":"2016","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13634","article-title":"Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer","volume":"8","author":"Sequeiros","year":"2017","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0468","article-title":"Placental exosomes viewed from an \u2018omics\u2019 perspective: implications for gestational diabetes biomarkers identification","volume":"13","author":"Herrera-Van Oostdam","year":"2019","journal-title":"biomark Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cmet.2020.06.016","article-title":"Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis","volume":"32","author":"Song","year":"2020","journal-title":"Cell Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00693-y","article-title":"Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker","volume":"23","author":"Kugeratski","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"18518","DOI":"10.1038\/s41598-021-97969-y","article-title":"Shotgun-based proteomics of extracellular vesicles in Alzheimer\u2019s disease reveals biomarkers involved in immunological and coagulation pathways","volume":"11","author":"Nielsen","year":"2021","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094367","article-title":"Biomarkers in prostate cancer diagnosis: From current knowledge to the role of metabolomics and exosomes","volume":"22","author":"Salciccia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1052765","article-title":"Potential blood biomarkers for chronic traumatic encephalopathy: the multi-omics landscape of an observational cohort","volume":"14","author":"Ge","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B38","doi-asserted-by":"crossref","first-page":"824378","DOI":"10.3389\/fimmu.2022.824378","article-title":"Preclinical studies on convalescent human immune plasma-derived exosome: Omics and antiviral properties to SARS-CoV-2","volume":"13","author":"Ta\u015fl\u0131","year":"2022","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1342429","article-title":"Biomarkers and molecular endotypes of sarcoidosis: lessons from omics and non-omics studies","volume":"14","author":"Ji","year":"2023","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00672-2024","article-title":"Targeted proteomics in extracellular vesicles identifies biomarkers predictive for therapeutic response in sarcoidosis","volume":"11","author":"Kraaijvanger","year":"2025","journal-title":"ERJ Open Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12931-024-02809-y","article-title":"Decreased serpin C1 in extracellular vesicles predicts response to methotrexate treatment in patients with pulmonary sarcoidosis","volume":"25","author":"Kraaijvanger","year":"2024","journal-title":"Respir Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1164\/rccm.200402-249oc","article-title":"Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis","volume":"16","author":"Judson","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.11.2106001","article-title":"Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS)","volume":"164","author":"Rybicki","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldg021","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/01.jom.0000155711.88781.91","article-title":"Job and industry classifications associated with sarcoidosis in a case-control etiologic study of sarcoidosis (ACCESS)","volume":"47","author":"Barnard","year":"2005","journal-title":"J Occup Environ Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817879.ch10","article-title":"ACCESS: A case control etiologic study of sarcoidosis","volume":"22","author":"Semenzato","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.8b00459","article-title":"Highly efficient phosphoproteome capture and analysis from urinary extracellular vesicles","volume":"17","author":"Wu","year":"2018","journal-title":"J Proteome Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2024-0193le","article-title":"Regenerative signatures in BAL of acute respiratory distress syndrome","volume":"71","author":"Zhao","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.s96","article-title":"Variance stabilization applied to microarray data calibration and to the quantification of differential expression","author":"Huber","year":"2002","journal-title":"Bioinformatics"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest--non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"B52","volume-title":"ggplot2: elegant graphics for data analysis","author":"H.","year":"2016"},{"key":"B53","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41467-024-44986-w","article-title":"Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients","volume":"15","author":"Duijvelaar","year":"2024","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00858","article-title":"pathfindR: An R package for comprehensive identification of enriched pathways in omics data through active subnetworks","volume":"10","author":"Ulgen","year":"2019","journal-title":"Front Genet"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3758\/bf03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2007.01061.x","article-title":"Elevated alpha-defensin levels in plasma of patients with pulmonary sarcoidosis","volume":"12","author":"Ashitani","year":"2007","journal-title":"Respirology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu101","article-title":"Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling","volume":"35","author":"Lassner","year":"2014","journal-title":"Eur Heart J"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00178111","article-title":"Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis","volume":"41","author":"Silva","year":"2013","journal-title":"Eur Respir J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00028209","article-title":"Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis","volume":"34","author":"Beirne","year":"2009","journal-title":"Eur Respir J"},{"key":"B61","first-page":"17","article-title":"Alterations in the membrane-associated proteome fraction of alveolar macrophages in sarcoidosis","volume":"33","author":"Kjellin","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2015.08.012","article-title":"A functional proteomics approach to the comprehension of sarcoidosis","volume":"128","author":"Landi","year":"2015","journal-title":"J Proteomics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-3083.1990.tb02738.x","article-title":"Synthesis of complement by alveolar macrophages from patients with sarcoidosis","volume":"31","author":"Pettersen","year":"1990","journal-title":"Scand J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12920-018-0338-x","article-title":"Whole exome sequencing in three families segregating a pediatric case of sarcoidosis","volume":"11","author":"Calender","year":"2018","journal-title":"BMC Med Genomics"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03832.x","article-title":"Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis","volume":"155","author":"Arakelyan","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1159\/000222681","article-title":"Elevated concentrations of liver-expressed chemokine\/CC chemokine ligand 16 in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia","volume":"150","author":"Nureki","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1744666x.2019.1568240","article-title":"Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis","volume":"15","author":"Ramos-Casals","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.06.004","article-title":"CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases","volume":"107","author":"Cai","year":"2013","journal-title":"Respir Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.11.065","article-title":"M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis","volume":"178","author":"Prokop","year":"2011","journal-title":"Am J Pathol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030617","article-title":"Genetic deletion of polo-like kinase 2 induces a pro-fibrotic pulmonary phenotype","volume":"10","author":"Kant","year":"2021","journal-title":"Cells"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.07.122","article-title":"All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling","volume":"491","author":"Leem","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141061","article-title":"Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF","volume":"6","author":"Hohmann","year":"2021","journal-title":"JCI Insight"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-1485","article-title":"Association between heat shock protein 70\/Hom genetic polymorphisms and uveitis in patients with sarcoidosis","volume":"48","author":"Spagnolo","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B74","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201407-1341OC","article-title":"Proteomic profiling reveals autoimmune targets in sarcoidosis","volume":"191","author":"H\u00e4ggmark","year":"2015","journal-title":"Am J Respir Crit Care Med"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1931341","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1779835\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:40:43Z","timestamp":1784551243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1779835\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":74,"alternative-id":["10.3389\/fimmu.2026.1779835"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1779835","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"article-number":"1779835"}}